TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis
Authors:
- B. ThorgilssonBTB. Thorgilsson
- J. BjörnssonJBJ. Björnsson
- L. TryggvadottirLTL. Tryggvadottir
- A.-L. BörresenABA.-L. Börresen
- H.M. ÖgmundsdottirHÖH.M. Ögmundsdottir
- J.E. EyfjördJEJ.E. Eyfjörd
- 1 October 1995
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 31 (11) , 1856-1861
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Multifactorial analysis of p53 alteration in human cancer: A reviewInternational Journal of Cancer, 1994
- The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesisBritish Journal of Cancer, 1994
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992
- Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumoursThe Lancet, 1992
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other NeoplasmsScience, 1990
- p53: oncogene or anti-oncogene?Genes & Development, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Detection of antibodies against the cellular protein p53 in sera from patients with breast cancerInternational Journal of Cancer, 1982